Indivior PharmaceuticalsINDV
那斯達克 · USD
34.13
-0.19
(-0.55%)
盤中 09/09 11:39 (UTC+8)
09/09 11:39 (UTC+8)
Indivior PharmaceuticalsINDV
34.13
-0.19
(-0.55%)
財務數據
損益表
- 2.84
- 2.99
- 3.07
- 2.99
- 2.66
- 3.02
- 3.13
- 3.58
- 3.17
- 3.43
- -3.07
- 5.28
- 2.68
- -2.61
- -11.04
- 13.53
- 3.64
- 14.38
- -11.45
- 8.20
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 343,000 | 317,000 | 358,000 | 313,000 | 302,000 | 266,000 | 299,000 | 307,000 | 299,000 | 284,000 |
營業成本 | 50,000 | 40,000 | 67,000 | 83,000 | 52,000 | 44,000 | 23,000 | 66,000 | 79,000 | 38,000 |
營業毛利 | 293,000 | 277,000 | 292,000 | 230,000 | 251,000 | 221,000 | 276,000 | 241,000 | 220,000 | 246,000 |
營業費用 | 133,000 | 140,000 | 210,000 | 187,000 | 178,000 | 155,000 | -16,000 | 168,000 | 178,000 | 172,000 |
研發費用 | 12,000 | 16,000 | 21,000 | 33,000 | 21,000 | 22,000 | 31,000 | 22,000 | 26,000 | 28,000 |
推銷及管理費用 | 121,000 | 124,000 | 187,000 | 153,000 | 157,000 | 132,000 | -47,000 | 142,000 | 152,000 | 144,000 |
非經常性項目費用 | - | - | 2,000 | 1,000 | - | 1,000 | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | 4,000 | - | - |
營業利益 | 159,000 | 137,000 | 81,000 | 43,000 | 72,000 | 66,000 | 292,000 | 73,000 | 42,000 | 74,000 |
其他收入及費用 | 2,000 | -15,000 | 6,000 | 6,000 | 6,000 | 4,000 | - | - | - | - |
利息費用 | 2,000 | 7,000 | 6,000 | 12,000 | 15,000 | 12,000 | 13,000 | 11,000 | 9,000 | 9,000 |
稅前純益 | 161,000 | 115,000 | 81,000 | 37,000 | 62,000 | 59,000 | 88,000 | 30,000 | -121,000 | 73,000 |
所得稅 | 39,000 | 26,000 | -21,000 | -6,000 | 45,000 | 11,000 | 28,000 | 8,000 | -23,000 | 11,000 |
稅後純益 | 122,000 | 89,000 | 102,000 | 43,000 | 18,000 | 47,000 | 59,000 | 22,000 | -97,000 | 61,000 |
基本每股稅後盈餘(元) | 1.02 | 0.71 | 0.82 | 0.34 | 0.15 | 0.38 | 0.07 | 0.03 | -0.79 | 0.45 |
稀釋每股稅後盈餘(元) | 0.98 | 0.69 | 0.79 | 0.33 | 0.14 | 0.38 | 0.07 | 0.03 | -0.79 | 0.45 |
基本平均股數(千股) | 119000.00 | 124000.00 | 124390.00 | 125000.00 | 125000.00 | 123684.00 | 126611.00 | 132103.00 | 134848.00 | 136000.00 |
稀釋平均股數(千股) | 124000.00 | 129000.00 | 129113.00 | 129000.00 | 126000.00 | 123684.00 | 128080.00 | 133552.00 | 137290.00 | 137000.00 |
還原基本每股稅後盈餘(元) | 1.02 | 0.71 | 0.82 | 0.34 | 0.15 | 0.38 | 0.07 | 0.03 | -0.79 | 0.45 |
還原稀釋每股稅後盈餘(元) | 0.98 | 0.69 | 0.79 | 0.33 | 0.14 | 0.38 | 0.07 | 0.03 | -0.79 | 0.45 |
還原基本平均股數(千股) | 119,000 | 124,000 | 124,390 | 125,000 | 125,000 | 123,684 | 126,611 | 132,103 | 134,848 | 136,000 |
還原稀釋平均股數(千股) | 124,000 | 129,000 | 129,113 | 129,000 | 126,000 | 123,684 | 128,080 | 133,552 | 137,290 | 137,000 |
EBITDA(千元) | 167,000 | 126,000 | 92,000 | 54,000 | 83,000 | 75,000 | 100,000 | 49,000 | -105,000 | 86,000 |